{
    "nct_id": "NCT05294120",
    "official_title": "A Phase II Trial of Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided RadIation TherapY: CLARITY",
    "inclusion_criteria": "* Biopsy proven basal cell carcinoma\n\n  °Up to 3 tumors per patient can be treated per protocol synchronously or metachronously\n* Clinical stage T1 or T2 by Union International to Control Cancer 8th edition system\n\n  * ≤40 mm in maximum dimension\n  * no deep invasion (beyond subcutaneous fat or >6 mm from granular later of dermis to deepest point of carcinoma)\n  * no perineural invasion of nerves ≥0.1 mm diameter or deeper than dermis\n  * no intraneural invasion\n  * no bone erosion, invasion or foraminal transgression NOTE: For the purposes of protocol inclusion, if any of the features mentioned above is not included in the pathology report they will considered absent.\n* ≥18 years old\n* Amenable to RCM/OCT and radiation therapy in opinion of investigator\n\n  * Some anatomic locations may preclude imaging by RCM/OCT may not be amenable to RCM/OCT imaging\n  * Some medical comorbidities may preclude the delivery of radiation therapy (conditions rendering patients hypersensitive to ionizing radiation, or unable to undergo treatment)\n* Able and willing to complete the Skindex 16 and Skin Cancer Index (must be able to understand English or Spanish)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Medical contraindication to radiation therapy in the opinion of the investigator\n* Prior cancer radiotherapy which precludes the ability to safely deliver radiation therapy in the opinion of the investigator\n* High likelihood of protocol non-compliance in the opinion of the investigator °Patients who demonstrate unwillingness to undergo protocol-defined treatment or follow-up procedures will be ineligible to participate",
    "miscellaneous_criteria": ""
}